India May Roll Out Low-Cost ‘Miracle Drug’ for Haemophilia A: Emicizumab Under Review
From Rs 13 Lakh to Rs 5 Lakh: India Eyes Affordable Emicizumab for Bleeding Disorder New Delhi: The Central Government is evaluating a proposal to replace the current standard haemophilia …
India May Roll Out Low-Cost ‘Miracle Drug’ for Haemophilia A: Emicizumab Under Review Read More